Improving survival in inflammatory rheumatic diseases: a neglected goal? Theodore PincusAllan GibofskyJ. Timothy Harrington Invited Commentary Pages: 401 - 403
Dietary factors as novel therapies for muscle pain Roland Staud Clinical Trials Report Pages: 409 - 410
Placebo analgesia: Friend or foe? Donald D. PriceRoger B. FillingimMichael E. Robinson OriginalPaper Pages: 418 - 424
Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: New trends and future directions Jennifer M. Glass OriginalPaper Pages: 425 - 429
Are patients with systemic lupus erythematosus at increased risk for Fibromyalgia? Roland Staud OriginalPaper Pages: 430 - 435
Prospective, open-label trial of rituximab in childhood systemic lupus erythematosus Emma Jane MacDermottThomas J. A. Lehman Clinical Trials Report Pages: 439 - 440
Safety and efficacy of rituximad to treat systemic lupus erythematosus in children Emma Jane MacDermottThomas J. A. Lehman Clinical Trials Report Pages: 440 - 441
Update on the medical treatment of juvenile idiopathic arthritis Philip J. HashkesRonald M. Laxer OriginalPaper Pages: 450 - 458
Ocular complications of childhood rheumatic diseases: Uveitis Andreas Reiff OriginalPaper Pages: 459 - 468
Osteogenesis imperfecta: New treatment options Guillaume ChevrelRolando Cimaz OriginalPaper Pages: 474 - 479